Drug Type Small molecule drug |
Synonyms Nadide, CO-I, NSC-20272 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jul 2011), |
Regulation- |
Molecular FormulaC21H27N7O14P2 |
InChIKeyBAWFJGJZGIEFAR-NNYOXOHSSA-N |
CAS Registry53-84-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Coenzyme I | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Coronary Artery Disease | China | 01 Jul 2011 | |
| Leukopenia | China | 01 Jul 2011 | |
| Myocarditis | China | 01 Jul 2011 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Heart Failure | Phase 2 | China | 24 Jun 2025 | |
| ST Elevation Myocardial Infarction | Phase 2 | China | 24 Jun 2025 |





